Compounds > tulobuterol
Page last updated: 2024-11-05

tulobuterol and Atrioventricular Conduction Block

tulobuterol has been researched along with Atrioventricular Conduction Block in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Tulobuterol is a selective β2-adrenoceptor agonist, widely used safely as bronchodilator in children."5.48A Case of Congenital Complete Atrioventricular Block Treated with Transdermal Tulobuterol. ( Ashina, M; Deguchi, M; Fujioka, K; Fukushima, S; Iijima, K; Ikuta, T; Morioka, I; Morizane, M; Ohyama, S; Okubo, S; Sato, Y; Tanimura, K; Yamada, H; Yamana, K, 2018)
"Tulobuterol is a selective β2-adrenoceptor agonist, widely used safely as bronchodilator in children."1.48A Case of Congenital Complete Atrioventricular Block Treated with Transdermal Tulobuterol. ( Ashina, M; Deguchi, M; Fujioka, K; Fukushima, S; Iijima, K; Ikuta, T; Morioka, I; Morizane, M; Ohyama, S; Okubo, S; Sato, Y; Tanimura, K; Yamada, H; Yamana, K, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikuta, T1
Fujioka, K1
Sato, Y1
Ashina, M1
Fukushima, S1
Ohyama, S1
Okubo, S1
Yamana, K1
Morizane, M1
Tanimura, K1
Deguchi, M1
Iijima, K1
Morioka, I1
Yamada, H1

Other Studies

1 other study available for tulobuterol and Atrioventricular Conduction Block

ArticleYear
A Case of Congenital Complete Atrioventricular Block Treated with Transdermal Tulobuterol.
    The Kobe journal of medical sciences, 2018, Apr-19, Volume: 63, Issue:4

    Topics: Administration, Cutaneous; Adrenergic beta-Agonists; Adult; Atrioventricular Block; Female; Humans;

2018